Dr. Petryk’s Thoughts: A September 23, 2010 article in the New England Journal of Medicine announced that, finally, the FDA has stepped forward and decided on regulatory action for Avandia, a diabetes drug that last year claimed 1,354 lives as a result of cardiac-associated problems.
Has anyone thought about correcting the patient’s physiology instead of simply putting them on drugs??? Diabetes and HTN are the 2 most common diseases and the 2 most easiest to prevent and treat. Click here to learn how
